These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2955786)

  • 1. Chimeric peptides as a vehicle for peptide pharmaceutical delivery through the blood-brain barrier.
    Pardridge WM; Kumagai AK; Eisenberg JB
    Biochem Biophys Res Commun; 1987 Jul; 146(1):307-13. PubMed ID: 2955786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-endorphin chimeric peptides: transport through the blood-brain barrier in vivo and cleavage of disulfide linkage by brain.
    Pardridge WM; Triguero D; Buciak JL
    Endocrinology; 1990 Feb; 126(2):977-84. PubMed ID: 2137082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorptive-mediated endocytosis of cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport.
    Kumagai AK; Eisenberg JB; Pardridge WM
    J Biol Chem; 1987 Nov; 262(31):15214-9. PubMed ID: 2959663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-brain barrier transport of cationized immunoglobulin G: enhanced delivery compared to native protein.
    Triguero D; Buciak JB; Yang J; Pardridge WM
    Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4761-5. PubMed ID: 2734318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of peptides and proteins through the blood-brain barrier.
    Bickel U; Yoshikawa T; Pardridge WM
    Adv Drug Deliv Rev; 2001 Mar; 46(1-3):247-79. PubMed ID: 11259843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in peptide drug delivery to the brain.
    Pardridge WM
    Pharmacol Toxicol; 1992 Jul; 71(1):3-10. PubMed ID: 1523192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins.
    Triguero D; Buciak J; Pardridge WM
    J Neurochem; 1990 Jun; 54(6):1882-8. PubMed ID: 2338547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport of histone through the blood-brain barrier.
    Pardridge WM; Triguero D; Buciak J
    J Pharmacol Exp Ther; 1989 Dec; 251(3):821-6. PubMed ID: 2600816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of cationized rat albumin as a potential blood-brain barrier drug transport vector.
    Pardridge WM; Triguero D; Buciak J; Yang J
    J Pharmacol Exp Ther; 1990 Nov; 255(2):893-9. PubMed ID: 2243356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrovascular permeability to peptides: manipulations of transport systems at the blood-brain barrier.
    Zlokovic BV
    Pharm Res; 1995 Oct; 12(10):1395-406. PubMed ID: 8584471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery.
    Pardridge WM; Kang YS; Buciak JL
    Pharm Res; 1994 May; 11(5):738-46. PubMed ID: 8058646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid peptide drug development: transport of opioid chimeric peptides through the blood-brain barrier.
    Pardridge WM
    NIDA Res Monogr; 1992; 120():153-68. PubMed ID: 1501684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transport of recombinant CD4 through the rat blood-brain barrier in vivo.
    Pardridge WM; Buciak JL; Yoshikawa T
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1175-80. PubMed ID: 1602382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Des-Tyr1-gamma-endorphin (DT gamma E) and des-enkephalin-gamma-endorphin (DE gamma E): plasma profile and brain uptake after systemic administration in the rat.
    Verhoef JC; Scholtens H; Vergeer EG; Witter A
    Peptides; 1985; 6(3):467-74. PubMed ID: 4070016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aluminium increases permeability of the blood-brain barrier to labelled DSIP and beta-endorphin: possible implications for senile and dialysis dementia.
    Banks WA; Kastin AJ
    Lancet; 1983 Nov; 2(8361):1227-9. PubMed ID: 6139573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex.
    Saito Y; Buciak J; Yang J; Pardridge WM
    Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10227-31. PubMed ID: 7479757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain delivery of biotin bound to a conjugate of neutral avidin and cationized human albumin.
    Kang YS; Pardridge WM
    Pharm Res; 1994 Sep; 11(9):1257-64. PubMed ID: 7816753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of the disulfide bond in an avidin-biotin linked chimeric peptide during in vivo transcytosis through brain endothelial cells.
    Kang YS; Voigt K; Bickel U
    J Drug Target; 2000; 8(6):425-34. PubMed ID: 11328668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the blood-brain barrier to peptides: [3H]beta-casomorphin-5 uptake by eighteen brain regions in vivo.
    Ermisch A; Rühle HJ; Neubert K; Hartrodt B; Landgraf R
    J Neurochem; 1983 Nov; 41(5):1229-33. PubMed ID: 6619862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-brain barrier and peptides.
    Ermisch A; Rühle HJ; Landgraf R; Hess J
    J Cereb Blood Flow Metab; 1985 Sep; 5(3):350-7. PubMed ID: 3897253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.